Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Balance Sheet
Balance Sheet Decomposition
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
Balance Sheet
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
| Dec-2001 | Dec-2002 | Dec-2003 | Dec-2004 | Dec-2005 | Dec-2006 | Dec-2007 | Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||||||||
| Cash & Cash Equivalents |
27
|
83
|
197
|
241
|
274
|
262
|
219
|
163
|
240
|
228
|
350
|
413
|
1 182
|
1 251
|
1 472
|
1 706
|
2 085
|
2 782
|
4 232
|
2 412
|
7 084
|
2 412
|
1 159
|
1 483
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2 408
|
2 412
|
1 159
|
1 483
|
|
| Cash Equivalents |
27
|
83
|
197
|
241
|
274
|
262
|
219
|
163
|
240
|
228
|
350
|
413
|
1 182
|
1 251
|
1 472
|
1 706
|
2 085
|
2 782
|
4 232
|
2 412
|
4 677
|
0
|
0
|
0
|
|
| Short-Term Investments |
0
|
0
|
127
|
17
|
8
|
2
|
0
|
0
|
5
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
9
|
6 202
|
9 014
|
3 520
|
|
| Total Receivables |
84
|
65
|
44
|
45
|
70
|
115
|
116
|
136
|
138
|
134
|
143
|
154
|
175
|
209
|
365
|
477
|
640
|
617
|
777
|
738
|
875
|
1 037
|
1 183
|
1 089
|
|
| Accounts Receivables |
25
|
35
|
40
|
32
|
55
|
96
|
94
|
116
|
121
|
121
|
132
|
128
|
155
|
151
|
302
|
379
|
429
|
444
|
470
|
509
|
612
|
744
|
912
|
781
|
|
| Other Receivables |
59
|
30
|
4
|
13
|
15
|
19
|
22
|
20
|
17
|
13
|
11
|
26
|
20
|
58
|
63
|
98
|
211
|
173
|
307
|
229
|
263
|
293
|
271
|
308
|
|
| Inventory |
92
|
104
|
110
|
89
|
136
|
157
|
204
|
296
|
333
|
336
|
369
|
560
|
754
|
890
|
878
|
1 126
|
1 243
|
1 667
|
2 097
|
2 191
|
2 438
|
2 628
|
3 379
|
4 967
|
|
| Other Current Assets |
1
|
0
|
1
|
0
|
3
|
6
|
10
|
39
|
35
|
24
|
26
|
90
|
139
|
22
|
109
|
103
|
250
|
163
|
246
|
2 955
|
227
|
426
|
365
|
270
|
|
| Total Current Assets |
203
|
253
|
478
|
392
|
490
|
543
|
550
|
634
|
752
|
722
|
889
|
1 218
|
2 250
|
2 373
|
2 824
|
3 412
|
4 218
|
5 230
|
7 352
|
8 296
|
10 633
|
12 705
|
15 100
|
11 329
|
|
| PP&E Net |
67
|
68
|
83
|
85
|
92
|
84
|
161
|
170
|
191
|
183
|
199
|
242
|
283
|
340
|
318
|
281
|
274
|
257
|
263
|
494
|
613
|
677
|
826
|
1 820
|
|
| PP&E Gross |
67
|
68
|
83
|
85
|
92
|
84
|
161
|
170
|
191
|
183
|
199
|
242
|
283
|
340
|
318
|
281
|
274
|
257
|
263
|
494
|
613
|
677
|
826
|
1 820
|
|
| Accumulated Depreciation |
44
|
51
|
59
|
68
|
76
|
84
|
94
|
106
|
119
|
127
|
140
|
153
|
167
|
179
|
201
|
224
|
247
|
273
|
293
|
342
|
404
|
460
|
510
|
526
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
17
|
17
|
39
|
44
|
48
|
63
|
59
|
93
|
126
|
167
|
164
|
293
|
174
|
121
|
156
|
259
|
221
|
319
|
291
|
273
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
21
|
42
|
6
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
16
|
11
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
5
|
34
|
82
|
94
|
108
|
220
|
216
|
286
|
471
|
411
|
664
|
423
|
745
|
673
|
943
|
871
|
932
|
930
|
1 008
|
826
|
697
|
646
|
3 920
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
21
|
2
|
6
|
7
|
8
|
11
|
14
|
19
|
25
|
76
|
87
|
54
|
101
|
109
|
148
|
227
|
205
|
217
|
198
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
21
|
42
|
6
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
270
N/A
|
326
+21%
|
595
+83%
|
559
-6%
|
694
+24%
|
773
+11%
|
971
+26%
|
1 071
+10%
|
1 285
+20%
|
1 447
+13%
|
1 569
+8%
|
2 231
+42%
|
3 101
+39%
|
3 650
+18%
|
4 055
+11%
|
5 038
+24%
|
5 648
+12%
|
6 658
+18%
|
8 811
+32%
|
10 206
+16%
|
12 521
+23%
|
14 604
+17%
|
17 080
+17%
|
17 540
+3%
|
|
| Liabilities | |||||||||||||||||||||||||
| Accounts Payable |
2
|
18
|
3
|
1
|
50
|
58
|
69
|
69
|
62
|
87
|
66
|
76
|
72
|
67
|
87
|
147
|
162
|
191
|
206
|
222
|
322
|
363
|
506
|
436
|
|
| Accrued Liabilities |
10
|
17
|
22
|
6
|
13
|
18
|
25
|
41
|
34
|
29
|
49
|
25
|
38
|
59
|
63
|
52
|
56
|
88
|
124
|
169
|
375
|
401
|
714
|
506
|
|
| Short-Term Debt |
35
|
10
|
0
|
0
|
9
|
16
|
89
|
182
|
229
|
98
|
105
|
52
|
40
|
11
|
60
|
452
|
578
|
660
|
768
|
764
|
893
|
1 105
|
1 179
|
990
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
39
|
0
|
17
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
23
|
29
|
34
|
43
|
|
| Other Current Liabilities |
76
|
105
|
15
|
12
|
4
|
10
|
3
|
3
|
27
|
36
|
50
|
109
|
121
|
116
|
153
|
259
|
356
|
351
|
648
|
645
|
524
|
612
|
451
|
400
|
|
| Total Current Liabilities |
123
|
150
|
41
|
19
|
76
|
102
|
180
|
296
|
352
|
249
|
309
|
263
|
287
|
254
|
362
|
910
|
1 151
|
1 290
|
1 747
|
1 800
|
2 137
|
2 510
|
2 883
|
2 374
|
|
| Long-Term Debt |
0
|
20
|
0
|
0
|
0
|
0
|
0
|
0
|
20
|
30
|
0
|
314
|
298
|
299
|
299
|
300
|
0
|
0
|
0
|
0
|
87
|
109
|
143
|
213
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
8
|
31
|
11
|
28
|
51
|
42
|
67
|
13
|
66
|
47
|
32
|
30
|
15
|
48
|
47
|
75
|
61
|
30
|
0
|
|
| Minority Interest |
0
|
0
|
11
|
11
|
30
|
43
|
36
|
26
|
33
|
34
|
38
|
55
|
79
|
79
|
148
|
257
|
289
|
291
|
338
|
394
|
432
|
494
|
544
|
567
|
|
| Other Liabilities |
1
|
1
|
1
|
1
|
10
|
12
|
1
|
11
|
27
|
33
|
29
|
31
|
48
|
44
|
43
|
45
|
42
|
45
|
46
|
101
|
85
|
100
|
104
|
114
|
|
| Total Liabilities |
124
N/A
|
171
+38%
|
52
-70%
|
30
-42%
|
115
+283%
|
165
+43%
|
248
+50%
|
344
+39%
|
460
+34%
|
397
-14%
|
417
+5%
|
731
+75%
|
725
-1%
|
741
+2%
|
900
+21%
|
1 544
+72%
|
1 512
-2%
|
1 641
+9%
|
2 179
+33%
|
2 343
+8%
|
2 816
+20%
|
3 274
+16%
|
3 704
+13%
|
3 268
-12%
|
|
| Equity | |||||||||||||||||||||||||
| Common Stock |
100
|
100
|
140
|
140
|
140
|
140
|
140
|
140
|
140
|
140
|
140
|
140
|
161
|
161
|
402
|
603
|
603
|
603
|
603
|
603
|
603
|
603
|
603
|
603
|
|
| Retained Earnings |
26
|
35
|
95
|
78
|
128
|
154
|
194
|
266
|
320
|
445
|
603
|
855
|
1 157
|
1 421
|
1 745
|
2 142
|
2 787
|
3 674
|
4 686
|
5 862
|
7 816
|
9 559
|
11 602
|
12 497
|
|
| Additional Paid In Capital |
20
|
20
|
308
|
310
|
310
|
316
|
391
|
322
|
367
|
467
|
410
|
508
|
1 028
|
1 029
|
808
|
638
|
638
|
638
|
1 084
|
1 085
|
1 086
|
1 094
|
1 095
|
1 095
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
203
|
73
|
75
|
88
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
16
|
16
|
14
|
14
|
14
|
14
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
46
|
313
|
214
|
125
|
122
|
116
|
258
|
312
|
3
|
1
|
2
|
11
|
|
| Total Equity |
146
N/A
|
155
+6%
|
543
+250%
|
528
-3%
|
578
+9%
|
608
+5%
|
723
+19%
|
726
+0%
|
825
+14%
|
1 050
+27%
|
1 151
+10%
|
1 500
+30%
|
2 377
+58%
|
2 908
+22%
|
3 155
+8%
|
3 493
+11%
|
4 136
+18%
|
5 016
+21%
|
6 631
+32%
|
7 862
+19%
|
9 705
+23%
|
11 330
+17%
|
13 376
+18%
|
14 272
+7%
|
|
| Total Liabilities & Equity |
270
N/A
|
326
+21%
|
595
+83%
|
559
-6%
|
694
+24%
|
773
+11%
|
971
+26%
|
1 071
+10%
|
1 285
+20%
|
1 447
+13%
|
1 569
+8%
|
2 231
+42%
|
3 101
+39%
|
3 650
+18%
|
4 055
+11%
|
5 038
+24%
|
5 648
+12%
|
6 658
+18%
|
8 811
+32%
|
10 206
+16%
|
12 521
+23%
|
14 604
+17%
|
17 080
+17%
|
17 540
+3%
|
|
| Shares Outstanding | |||||||||||||||||||||||||
| Common Shares Outstanding |
414
|
414
|
580
|
580
|
580
|
573
|
573
|
573
|
573
|
573
|
573
|
573
|
544
|
544
|
603
|
603
|
603
|
603
|
603
|
603
|
603
|
603
|
603
|
603
|
|